Leukemia

The FDA approved the anti-CD19 immunotherapy Blincyto (blinatumomab) as a treatment for Philadelphia chromosome-negative acute lymphoblastic leukemia.

The CAR T-cell therapy JCAR015 received breakthrough therapy designation as a treatment for patients with relapsed or refractory B-cell ALL.

Approved and investigational agents have improved outcomes for patients with follicular lymphoma; however a growing understanding of the origins and progression of the disease might offer further insights for future clinical development.

Project: EveryChild is collecting biologic samples, such as blood, tissue and other specimens, from children undergoing treatment.

When deciding on a cancer treatment—and determining its effectiveness—look for a biomarker.

Goals and milestone recognitions may help children with cancer get through treatment a little easier.

Gazyva may become a standard treatment for older, sicker patient with CLL.

Long-term and late effects from toxic regimens from childhood cancer treatments include heart damage, lung problems and infertility.

Pediatric cancer treatment has come a long way, but health problems persist in survivorship.

A recent report notes that certain health issues observed in young adult survivors are typically seen in much older individuals.

Updates from the annual meeting of the American Society of Hematology.

Liposomal anthracycline may allow for higher dosing with less cardiotoxicity in childhood AML patients.

The latest in cancer prevention, diagnosis & treatment.

Oral anticancer therapy is available to treat different types of cancer and metastatic disease.

Ponatinib continues to make improvements in phase 2 CML study.

A study shows that a chemotherapy-free regimen may be better in acute promyelocytic leukemia.

When considering a stem cell transplantation, patients with cancer must be willing to take a chance.

Cancer research updates from the San Antonio Breast Cancer Symposium and American Society of Hematology.

Childhood and young adult cancer survivors need fertility preservation information, but are they getting it from their oncologists?

A kid can bring out the best in people.

Creating Hope for Childhood Cancer

Survival rates for ALL have increased to about 90 percent.

The latest in cancer prevention, diagnosis & treatment.

Minimizing and preventing late effects of stem cell transplantation.

Birth defects rare in kids of childhood cancer survivors.

In an early-phase study, PCI-32765, a BTK inhibitor, was shown to work against CLL, a type of non-Hodgkin lymphoma.

A novel drug called ponatinib that targets the BCR-ABL mutation overcomes a mutation that has been resistant to all previous approved therapies.

A drug removed from the market last year to treat acute myeloid leukemia may have a second life.

Research updates from the annual San Antonio Breast Cancer Symposium and American Society of Hematology.